Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.61 |
| ▸ | CXCL12 | P48061 | 4/20 | 0.58 |
| ▸ | AR | P10275 | 1/20 | 0.54 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.53 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.52 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.52 |
| ▸ | ABAT | P80404 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | APP | P05067 | 1/20 | 0.51 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formaldehyde SCHEMBL27485393 | 0.94 | MAOB (0.55) | MAOBCXCL12ARSLC22A6SLC22A8 | |
| Formic Acid SCHEMBL27641585 | 0.90 | TRIM24 (0.58) | MAOBCXCL12ARSLC22A6SLC22A8 | |
| SCHEMBL19425624 | 0.86 | SLC6A2 (0.50) | MAOBCXCL12ARKMT2AHPGD | |
| SCHEMBL16185272 | 0.85 | CXCL12 (0.46) | MAOBCXCL12ARSLC22A6SLC22A8 | |
| SCHEMBL7816115 | 0.84 | CXCL12 (0.65) | MAOBCXCL12CXCR4CSNK2A2CSNK2B | |
| SCHEMBL31142480 | 0.82 | MAPT (0.59) | MEN1KMT2AALDH1A1HPGDTDP1 | |
| SCHEMBL541591 | 0.82 | MAPT (0.59) | MEN1KMT2AALDH1A1HPGDTDP1 | |
| SCHEMBL27758491 | 0.79 | CALM1 (0.66) | ARALDH1A1TDP1TSHRCA2 | |
| SCHEMBL5317115 | 0.79 | NFE2L2 (0.73) | CXCL12ARAPPCXCR4CA2 | |
| SCHEMBL2951837 | 0.79 | NFE2L2 (0.73) | CXCL12ARAPPCXCR4CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 417 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240417568-A1 | ADHESION PROMOTER FOR COMPOSITES AND METHODS THEREOF | THE BOEING COMPANY (US) | 2024-12-19 | — | — | US | claimed |
| EP-4477720-A1 | ADHESION PROMOTER FOR COMPOSITES AND METHODS THEREOF | The Boeing Company (US) | 2024-12-18 | — | — | EP | claimed |
| US-20220372008-A1 | LUCIFERIN DERIVATIVES AND A METHOD FOR SYNTHESIS THEREOF | VIDYASIRIMEDHI INSTITUTE OF SCIENCE AND TECHNOLOGY (TH) | 2022-11-24 | — | — | US | claimed |
| CN-111454132-A | Method for synthesizing eugenol | 江西恒诚天然香料油有限公司 | 2020-07-28 | — | — | CN | claimed |
| CN-105503626-A | Synthesis method of 2-amino-4-chloro-6-metoxyphenol | UNIV CHANGZHOU | 2016-04-20 | — | — | CN | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| US-5149858-A | Reacting with chlorine gas in presence of organic cation catalysts | RHONE-POULENC CHIMIE (FR) | 1992-09-22 | — | — | US | claimed |
| EP-0216714-B1 | PROCESS FOR THE SELECTIVE CHLORINATION OF PHENOLIC COMPOUNDS | RHONE-POULENC CHIMIE (FR) | 1992-05-13 | — | — | EP | claimed |
| EP-0299891-B1 | PROCESS FOR THE SELECTIVE CHLORINATION OF PHENOLIC COMPOUNDS | RHONE-POULENC CHIMIE (FR) | 1991-12-11 | — | — | EP | claimed |
| US-4876396-A | AT ORTHO POSITION TO HYDROXYL; AMINE CATALYSTS | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1989-10-24 | — | — | US | claimed |
| EP-3704094-B1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | CALICO LIFE SCIENCES LLC (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20260001861-A1 | PYRIDINE CARBOXAMIDE COMPOUNDS FOR INHIBITING NAV1.8 | LIEBER INST INC (US) | 2026-01-01 | — | — | US | disclosed |
| US-12429417-B2 | Devices, systems, and methods for agrochemical detection and agrochemical compositions | SPOGEN BIOTECH, INC. (US) | 2025-09-30 | — | — | US | disclosed |
| US-12421193-B2 | GPR52 modulators and methods of use | NEUROCRINE BIOSCIENCES, INC. (US) | 2025-09-23 | — | — | US | disclosed |
| US-3980659-A | INSECTICIDES, INTERMEDIATES FOR AZO DYES | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-09-14 | — | — | US | disclosed |
| US-3956294-A | AZO DYES, PESTICIDES, ANALEPTICS, ANALGESICS, DIURETICS | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-05-11 | — | — | US | disclosed |
| US-3954782-A | 2,6-Hydrazino-3-pyridine carboxyamides | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-05-04 | — | — | US | disclosed |
| US-3947463-A | Certain 2-amino-nicotinonitrile derivatives | CASSELLA FARBWERKE MAINKUR AG (DT) | 1976-03-30 | — | — | US | disclosed |
| US-3946024-A | INTERMEDIATES FOR AZO DYES | CASSELLA FARBWERKE MAINKUR AG (DT) | 1976-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260001861-A1 | PYRIDINE CARBOXAMIDE COMPOUNDS FOR INHIBITING NAV1.8 | SCN8A, SCN1A, SCN1B | MAOB 987/4885CXCL12 4335/4885AR 3734/4885 |
| US-20220372008-A1 | LUCIFERIN DERIVATIVES AND A METHOD FOR SYNTHESIS THEREOF | NQO1, DDT, GLO1 | MAOB 52/4885CXCL12 3201/4885AR 4387/4885 |
| US-12421193-B2 | GPR52 modulators and methods of use | GPR52, GPR68, GPR35 | MAOB 947/4885CXCL12 3098/4885AR 743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.